Lead: A World Health Organization (WHO) analysis published in Nature Medicine in 2026 finds that more than a third of the nearly 19 million new cancer cases recorded in 2022 were linked to 30 changeable risk factors. Smoking and alcohol use account for the largest single lifestyle contributions—tobacco alone was associated with 15% of cases and 23% of male cases—while lung, stomach and cervical cancers together represent almost half of the preventable burden. The authors and WHO officials say targeted prevention—tobacco control, vaccination, pollution reduction and improved sanitation—could avert millions of cancers annually.
Key Takeaways
- About 19 million new cancer cases occurred in 2022; roughly 38% (≈7.2 million) are attributable to 30 modifiable risk factors identified by WHO and collaborators.
- Tobacco smoking is the single largest preventable factor, linked to 15% of all cancers in 2022 and 23% of cancers in men worldwide.
- Alcohol consumption was the next major lifestyle contributor, accounting for about 3.2% of new cases (≈700,000).
- Infections are implicated in roughly 10% of new cancers, with high‑risk human papillomavirus (HPV) a principal cause of preventable cervical cancer in women.
- Air pollution contributes regionally: about 15% of female lung cancers in East Asia and ~20% of male lung cancers in Northern Africa and Western Asia are linked to ambient air pollution.
- Other changeable risks include high body mass index, low physical activity, smokeless tobacco, areca nut use, suboptimal breastfeeding, ultraviolet radiation and a range of occupational exposures.
Background
The global cancer burden has steadily grown with population aging and growth; in 2022 nearly 19 million new diagnoses were recorded. Public health research has long separated non-modifiable risks (age, genetics) from modifiable exposures—behaviors, infections and environmental factors that can be reduced through policy or intervention. Previous national and regional studies showed that tobacco, alcohol, obesity and infections drive substantial fractions of cancer in many countries.
This WHO-led analysis synthesizes those lines of evidence to produce a global, comparative portrait of preventable cancer. The team quantified how much of the 2022 cancer incidence could be attributed to 30 risk factors that are, in principle, reducible—encompassing individual behaviors, infectious agents, occupational hazards and environmental pollution. By placing causes side by side, the study aims to guide countries toward interventions with the largest potential impact.
Main Event
The analysis, released in Nature Medicine in 2026, combined global incidence data with exposure estimates for 30 changeable risks to estimate population attributable fractions for each cancer type and region. The authors report that lung, stomach and cervical cancers make up almost half of cases tied to modifiable causes, reflecting the strong links between those cancers and smoking, infections (including HPV and Helicobacter pylori), and environmental exposures.
WHO medical epidemiologist Isabelle Soerjomataram, the study’s senior author, emphasized prevention as a leading opportunity to reduce cancer burden. The report highlights that tobacco control remains the single most effective lever worldwide, especially for men, where smoking accounted for nearly one in four new cancer cases in 2022.
Air pollution emerged as a significant regional driver of lung cancer, with the study noting that in East Asia about 15% of female lung cancer cases were attributable to ambient pollution and that in Northern Africa and Western Asia roughly 20% of male lung cancers were linked to pollution. The analysis also draws attention to cultural and occupational exposures such as areca nut chewing and smokeless tobacco in specific populations.
The authors and WHO experts called for multisectoral action: stronger tobacco and alcohol policies, broader HPV vaccine coverage, improved sanitation and clean‑water access, reductions in air pollution, and occupational safety enforcement to lower exposure to carcinogens on the job.
Analysis & Implications
The finding that 38% of 2022 cancers were attributable to changeable risks reframes many cancer control strategies toward prevention rather than detection and treatment alone. For countries with high smoking prevalence, intensified tobacco taxation, packaging regulations and cessation support would likely yield the largest returns in avoided cancers and deaths. The disproportionate male burden from smoking underscores the need for gender‑targeted tobacco interventions.
Alcohol’s contribution—3.2% of new cases—while smaller than tobacco’s, still represents roughly 700,000 preventable cancers annually, indicating that policies limiting availability, marketing and affordability of alcohol could produce meaningful reductions. For infection‑driven cancers, scaling up HPV vaccination and screening for cervical cancer remain high-impact, cost‑effective measures, especially where coverage is currently low.
Environmental and occupational drivers complicate prevention efforts because they require coordination across ministries (health, environment, labor) and often substantial infrastructure investment. The regional air pollution signals in the report suggest that clean‑air policies would reduce not only respiratory disease but also lung cancers, with particularly large benefits in heavily polluted urban regions.
Comparison & Data
| Risk Factor | Share of 2022 Cases | Approx. Cases (2022) |
|---|---|---|
| Tobacco smoking | 15% | ~2.85 million |
| Alcohol consumption | 3.2% | ~700,000 |
| Infections (incl. HPV) | 10% | ~1.9 million |
| All changeable risks combined | 38% | ~7.2 million |
These estimates combine global incidence (≈19 million cases in 2022) with exposure data for each risk. Attribution percentages vary substantially by region, sex and cancer type; for example, tobacco’s share rises in countries with high male smoking prevalence, while infection-related fractions are larger where vaccine coverage and sanitation are limited.
Reactions & Quotes
“Addressing these preventable causes represents one of the most powerful opportunities to reduce the global cancer burden.”
Isabelle Soerjomataram, WHO (medical epidemiologist, senior author)
This comment frames prevention as a strategic priority and underscores the potential scale of impact if modifiable risks are addressed through public health policy.
“By examining patterns across countries and population groups, we can provide governments and individuals with more specific information to help prevent many cancer cases before they start.”
André Ilbawi, WHO (Team Lead for Cancer Control, co‑author)
Ilbawi’s statement highlights the study’s comparative approach and its intended use as a policy and planning tool for governments seeking targeted prevention strategies.
Unconfirmed
- Attribution estimates depend on exposure data quality; in some low‑resource settings exposure measurement is limited, which can bias regional PAFs.
- Long latency between exposure and cancer onset means recent changes in exposure (for example, falling smoking rates) may not yet be reflected fully in 2022 incidence.
- Precise HPV vaccine coverage rates and subnational disparities were noted as low in parts of the world in reporting, but the study did not provide a uniform global coverage figure.
Bottom Line
The WHO analysis published in Nature Medicine shows that a substantial share—about 38%—of 2022’s nearly 19 million new cancer cases is theoretically preventable through interventions that reduce tobacco use, alcohol consumption, infections, pollution and occupational exposures. Tobacco control remains the highest‑impact single measure globally, especially for men, while vaccination, improved sanitation and pollution abatement are essential complementary strategies.
For policymakers, the study provides a prioritized map of where investments in prevention could yield the largest reductions in future cancer. For individuals, the findings reinforce established preventive actions—avoid tobacco, limit alcohol, support vaccination and advocate for cleaner air and safer workplaces—that collectively could prevent millions of cancers each year.
Sources
- ScienceAlert (media report summarizing the WHO/Nature Medicine analysis)
- Nature Medicine (academic journal; original study published 2026)
- World Health Organization (WHO) (official public health agency)